Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab. [electronic resource]
Producer: 20100322Description: 7069-76 p. digitalISSN:- 1557-3265
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Biopsy
- Cell Line, Tumor
- Colorectal Neoplasms -- drug therapy
- Combined Modality Therapy -- methods
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Middle Aged
- Neoplasm Metastasis
- RNA, Messenger -- metabolism
- Radiation-Sensitizing Agents -- therapeutic use
- Radiotherapy -- methods
- Radiotherapy, Conformal -- methods
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.